B2B meetings with Polish companies at “Apteka 2013”
Ladies and Gentleman,
We have a great honor of inviting you to the session of B2B meetings with Polish companies from pharmaceutical and biotechnology industries under international Apteka 2013 trades. The event will be visited by the representatives of the finest Polish companies, such as: Bestpharma, Biovico, Biofarm, Hasco-Lek, Zaklady Farmaceutyczne Unia, Komtur profiles of which are provided hereunder.
Venue: Pavilion No 7 Ekspocetre, conference room no 2;
Time: 11 December 2013 from 10:00 to 13:00.
Borowskiego 2/3, 5th floor, 03-475 Warszawa
Тел: +48 22 247 2898
Bestpharma was founded in pursuit of excellence. By focusing all of our attention on the customers' needs and by meeting all their expectations we managed to establish a strong position on the polish market. This could be accomplished by gaining trust of dietary supplements, nutraceuticals, and OTC manufacturers. Thanks to establishing and developing direct contacts with ingredients manufacturers all over the world, we are able to supply high quality with the best possible prices. The quality of customer relations is also one of the reasons why companies choose us as a partner. We work with the customer to best fit his needs and meet his expectations.
BIOFARM Sp. z o.o.
Walbrzyska 13; 60-198 Poznan
Phone: +48 61 665 15 00
Core business: Biofarm Sp. z o.o. is one of Poland’s leading producers of pharmaceuticals. They were one of the first pharmaceutical companies in Poland to have received the GMP certificate confirming their compliance with the highest quality standards for pharmaceutical production. Some of their projects enjoy EU funding. This includes their research projects under the Technological Initiative programme. In addition to perfecting its technological processes and products, Biofarm is expanding its operations outside Poland into other East and Central European Countries and the Far East.
Products and services highlights: Since Biofarm’s first medicine, Theospirex retard 300mg, had its market debut in 1992, the company has produced and supplied approx. 135m of various drug packages. Their portfolio includes 53 registered medicinal products and numerous dietary supplements. Currently, Biofarm manufactures a number of leading over-the-counter brands, such as Ginkofar, Bioprazol Bio, Magnefar B6, Soyfem or Halset, and a wide array of prescription drugs (Rx), including those for neurological and heart conditions or internal diseases. They also produce a large number of dietary supplements.
Biovico Sp. z o.o.
Hryniewickiego 6B/135; 81-340 Gdynia
Phone: +48 58 660 44 88
Core business: Biovico is a privately-owned small biotech company established in 2008. The company mission is to develop and distribute high quality and innovative nutraceuticals to Polish and European markets. To extend core business, in 2011 Biovico established R&D division to search for innovative molecules and products, in two major therapeutic areas: Inflammation/Rheumatology/Arthritis and Oncology.
Products and services highlights: Biovico is exclusive distributor of several innovative products to Polish market. The main products offered by Biovico are innovative nutraceuticals.
Komtur Polska Sp. z o.o.
Pulawska 405a; 02-801 Warszawa
Phone: + 48 22 544 09 51
Core business: Komtur Polska was established in 2004 in Warsaw as part of Komtur Pharmaceuticals Group - one of the world’s leading providers of integrated procurement services for pharmaceutical products. Since then the company has been a reliable partner in the distribution of drugs for clinical research. Its clients in the industry are leading manufacturers, research organizations and packaging specialists in the area of study drugs.
Products and services highlights: Komtur Polska is a pharmaceutical company that specializes in clinical distribution services and special distribution projects. The company is also an important supplier of hospital-only pharmaceutical products (oncology, cardiology, hematology) and a leading Polish ultra-orphan drugs distributor. One of Komtur’s main projects is CEE Center of Logistics for Clinical Trials in Warsaw (new facility project under construction).
HASCO-LE K S.A. Przedsiebiorstwo Produkcji Farmaceutycznej
Zmigrodzka 242E; 51-131 Wroclaw
Phone: +48 71 327 19 51/56
Core business: The company PPF Hasco-Lek S.A. manufactures pharmaceutical preparations and dietary supplements in the form of soft gelatin capsules, syrups, suspensions, drops, tablets, ointments, gels and suppositories. The company offers about 200 preparations for which the company would like to find new foreign markets.
Products and services highlights: The largest portion of the profits from PPF Hasco-Lek S.A. sales comes from soft gelatin capsules which are dominated by vitamins, minerals, nutrients and analgesics. The second form is fluids, among which the largest share is the preparations for cough, flu and other respiratory diseases. PPF Hasco-Lek S.A. is also involved in contract manufacturing of medicinal products and dietary supplements.
UNIA Spoldzielnia Pracy Zaklady Farmaceutyczne
Chlodna 56/60; 00-872 Warszawa
Phone: +48 22 620 90 81 to 86
Core business: ZF UNIA is a Polish pharmaceutical company established in 1937. The company manufactures and markets drugs and cosmetics for the Polish market and for export to Eastern Europe and Asia. The company’s headquarters and main manufacturing facilities are located in Warsaw. Each year it launches new medicinal products in the Rx and OTC segment and in the dermocosmetic segment.
Products and services highlights: ZF Unia produce pills, creams, ointments, gels, powders and liquid forms of medications. They also manufacture cosmetic aerosols, technical and medical devices.